CAS RN: 130657-47-5
(3aR,4R,6aS)-rel-octahydrocyclopenta[c]pyrrol-4-ol hydrochloride
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
97% (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20250411
100mg / 250mg
Out of stock
8-10 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 130657-47-5
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥95%
0
Out of Stock
Hong Kong
Inquiry
130657-47-5 / (3aR,4R,6aS)-1,2,3,3a,4,5,6,6a-octahydrocyclopenta[c]pyrrol-4-ol;hydrochloride
Standard CAS: 130657-47-5
Multi CAS: No
Basic Information
copy
CAS
130657-47-5 copy
Multi CAS
No copy
Molecular Formula
C7H14ClNO copy
Molecular Weight
163.640000 copy
Exact Mass
163.076392 copy
SMILES
C1C[C@H]([C@@H]2[C@H]1CNC2)O.Cl copy
InChI
InChI=1S/C7H13NO.ClH/c9-7-2-1-5-3-8-4-6(5)7;/h5-9H,1-4H2;1H/t5-,6+,7-;/m1./s1 copy
InChIKey
ZWFNCJOAGYAXQO-FNCXLRSCSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
10 copy
Fraction Csp3
1 copy
H-bond acceptors
2 copy
H-bond donors
2 copy
Molar refractivity
42.34 copy
TPSA
32.26 copy
LogP / Solubility
WLOGP
0.4 copy
MLOGP
0.35 copy
XLogP3
0.4 copy
Consensus LogP
0.38 copy
Log S (ESOL)
-1.11 copy
Class (ESOL)
Soluble copy
Log S (Ali)
-1.19 copy
Class (Ali)
Soluble copy
Log S (SILICOS-IT)
-1.05 copy
Class (SILICOS-IT)
Soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-3.44 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
No copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
3 copy